In principle, SRSF6 promotes phosphatidylinositol-binding clathrin assembly protein (PICALM) exon 14 inclusion to produce a full-length PICALM protein, which is required for the autophagy-induced resistance of gastric cancer cells to oxaliplatin and 5-FU (Zhang et al., 2021). Here, PICALM is linked to gastric cancer.